Neil Elliot Kay, MD

  • 19425 Citations
  • 74 Scopus h-Index
1973 …2020
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1973 2019

Filter
Letter
Letter

CHRONIC LYMPHOCYTIC LEUKAEMIA: AN AIDS LIKE DISEASE?

Millard, R. E. & Kay, N. E., 1986, In : British Journal of Haematology. 64, 4, p. 841-842 2 p.

Research output: Contribution to journalLetter

Lymphoid Leukemia
B-Cell Chronic Lymphocytic Leukemia
Acquired Immunodeficiency Syndrome
Differential Diagnosis
5 Citations (Scopus)

Chronic lymphocytic leukemia international prognostic index: A systematic review and meta-analysis

Molica, S., Giannarelli, D., Mirabelli, R., Levato, L., Kay, N. E. & Shanafelt, T. D., Jan 18 2018, In : Blood. 131, 3, p. 365-368 4 p.

Research output: Contribution to journalLetter

B-Cell Chronic Lymphocytic Leukemia
Meta-Analysis
1 Citation (Scopus)

KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival

Vendramini, E., Bomben, R., Pozzo, F., Benedetti, D., Bittolo, T., Rossi, F. M., Dal Bo, M., Rabe, K. G., Pozzato, G., Zaja, F., Chiarenza, A., Di Raimondo, F., Braggio, E. D., Parikh, S. A., Kay, N. E., Shanafelt, T. D., Del Poeta, G., Gattei, V. & Zucchetto, A., Jan 1 2019, In : Leukemia.

Research output: Contribution to journalLetter

Open Access
Trisomy
B-Cell Chronic Lymphocytic Leukemia
Mutation
3 Citations (Scopus)

Outcomes of a large cohort of individuals with clinically ascertained high-count monoclonal B-cell lymphocytosis

Parikh, S. A., Chaffee, K. G., Larson, M. C., Hampel, P. J., Call, T. G., Ding, W. D., Kenderian, S., Leis, J. F., Chanan Khan, A. A., Conte, M. J., Bowen, D., Schwager, S. M., Slager, S. L., Hanson, C. A., Kay, N. E. & Shanafelt, T. D., Jun 3 2018, In : Haematologica. 103, 6, p. e237-e240

Research output: Contribution to journalLetter

Lymphocytosis
B-Lymphocytes

Predictive value of the CLL-IPI in CLL patients receiving chemo-immunotherapy as first-line treatment

Gentile, M., Shanafelt, T. D., Mauro, F. R., Reda, G., Rossi, D., Laurenti, L., Del Principe, M. I., Cutrona, G., Angeletti, I., Coscia, M., Herishanu, Y., Chiarenza, A., Molica, S., Ciolli, S., Goldschmidt, N., Angrilli, F., Giordano, A., Rago, A., Bairey, O., Tripepi, G. & 17 others, Chaffee, K. G., Parikh, S. A., Vigna, E., Zirlik, K., Shvidel, L., Innocenti, I., Recchia, A. G., Di Raimondo, F., Del Poeta, G., Cortelezzi, A., Neri, A., Ferrarini, M., Gaidano, G., Kay, N. E., Polliack, A., Foà, R. & Morabito, F., Nov 1 2018, In : European Journal of Haematology. 101, 5, p. 703-706 4 p.

Research output: Contribution to journalLetter

Immunotherapy
Therapeutics
5 Citations (Scopus)

Renal insufficiency is an independent prognostic factor in patients with chronic lymphocytic leukemia

Strati, P., Chaffee, K. G., Achenbach, S. J., Slager, S. L., Leung, N., Call, T. G., Ding, W. D., Parikh, S. A., Kay, N. E. & Shanafelt, T. D., 2017, In : Haematologica. 102, 1, p. e22-e25

Research output: Contribution to journalLetter

B-Cell Chronic Lymphocytic Leukemia
Renal Insufficiency

Reply to S. Opat et al

Brown, J. R. & Kay, N. E., Dec 20 2017, In : Journal of Clinical Oncology. 35, 36, p. 4094-4095 2 p.

Research output: Contribution to journalLetter

5 Citations (Scopus)

T and B Lymphocytes in Chronic Lymphocytic Leukemia

Nowell, P., Daniele, R., Rowlands, D., Winger, L., Douglas, S. D., Kay, N. E., Hsu, C. C. S. & Davis, S., Aug 26 1976, In : New England Journal of Medicine. 295, 9, p. 504-505 2 p.

Research output: Contribution to journalLetter

B-Cell Chronic Lymphocytic Leukemia
B-Lymphocytes
T-Lymphocytes
Mitogens
Cell Count
33 Citations (Scopus)

The efficacy of ibrutinib in the treatment of Richter syndrome

Tsang, M., Shanafelt, T. D., Call, T. G., Ding, W. D., Chanan Khan, A. A., Leis, J. F., Nowakowski, G. S., Bowen, D., Conte, M., Schwager, S. M., Slager, S. L., Kay, N. E., Hanson, C. A. & Parikh, S. A., 2015, In : Blood. 125, 10, p. 1676-1678 3 p.

Research output: Contribution to journalLetter

Murine-Derived Monoclonal Antibodies
Antineoplastic Combined Chemotherapy Protocols
Pyrazoles
Pyrimidines
Lymphoma, Large B-Cell, Diffuse